FDA Approves Unknown Drug — GENUS LIFESCIENCES
GENUS LIFESCIENCES received U.S. approval on Oct. 20 for NDA200534, a drug application; this regulatory milestone positions the company to potentially expand its market footprint pending launch and commercial performance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day